Calvo, E <br/><br/>
Assessment of erlotinib pharmacodynamics in tumors and skin of patients with head and neck cancer.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Apr 2007 
 - 761-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0923-7534 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdl495  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Carcinoma, Squamous Cell--chemistry<br/>Cyclin-Dependent Kinase Inhibitor p27--analysis<br/>ErbB Receptors--analysis<br/>Erlotinib Hydrochloride<br/>Extracellular Signal-Regulated MAP Kinases--analysis<br/>Female<br/>Head and Neck Neoplasms--chemistry<br/>Humans<br/>Immunohistochemistry<br/>Male<br/>Middle Aged<br/>Quinazolines--adverse effects<br/>Skin--drug effects